Literature DB >> 4451747

Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.

M D Day, A G Roach.   

Abstract

1 In conscious unrestrained cats noradrenaline, alpha-methylnoradrenaline and clonidine, infused into the lateral cerebral ventricles (i.c.v.) caused dose-related falls in blood pressure and heart rate; both effects were abolished after i.c.v. phentolamine.2 In 12 out of 20 cats, i.c.v. isoprenaline and salbutamol when given caused dose-related pressor responses and tachycardias. These effects were abolished after i.c.v. beta-adrenoceptor blocking drugs but were unaffected by alpha-adrenoceptor blocking agents.3 In 5 out of 20 cats, i.c.v. isoprenaline regularly produced dose-related falls in blood pressure with associated tachycardias; both effects were abolished after i.c.v. beta-adrenoceptor blocking agents.4 Intracerebroventricular dopamine produced cardiovascular responses which were qualitatively similar to those produced by i.c.v. isoprenaline.5 Intracerebroventricular adrenaline produced complex responses in untreated animals but typical alpha-effects were obtained after prior i.c.v. treatment with a beta-adrenoceptor blocking agent and typical beta-effects after i.c.v. pretreatment with an alpha-adrenoceptor blocking agent.6 The cardiovascular changes produced by i.c.v. beta-adrenoceptor agonists were abolished after systemic administration of hexamethonium or bethanidine.7 The results are discussed in the light of the mode of action of beta-adrenoceptor stimulants and beta-adrenoceptor blocking agents in the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451747      PMCID: PMC1776783          DOI: 10.1111/j.1476-5381.1974.tb10666.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane.

Authors:  H Schmitt; S Fenard
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

2.  Centrally mediated cardiovascular responses to isoprenaline.

Authors:  D J Gagnon; K I Melville
Journal:  Int J Neuropharmacol       Date:  1967-07

3.  Central hypotensive effect of alpha-methyldopa.

Authors:  M Henning; P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1968-06       Impact factor: 3.765

Review 4.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

5.  Cardiovascular responses to carotid and vertebral artery infusions of propranolol.

Authors:  S Stern; M Hoffman; K Braun
Journal:  Cardiovasc Res       Date:  1971-10       Impact factor: 10.787

6.  Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures.

Authors:  H Schmitt; J R Boissier; J F Giudicelli; J Fichelle
Journal:  Eur J Pharmacol       Date:  1968-03       Impact factor: 4.432

7.  Central hypotensive activity of dl- and d-propranolol.

Authors:  G J Kelliher; J P Buckley
Journal:  J Pharm Sci       Date:  1970-09       Impact factor: 3.534

8.  Cardiovascular effects of sympathomimetic amines injected into the cerebral ventricles of rabbits.

Authors:  N Toda; Y Matsuda; K Shimamoto
Journal:  Int J Neuropharmacol       Date:  1969-09

9.  [Effect of sympathomimetics on the vasomotor centers].

Authors:  H Schmitt; S Fénard
Journal:  Arch Int Pharmacodyn Ther       Date:  1971-04

10.  Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain.

Authors:  J F Hayden; L R Johnson; R P Maickel
Journal:  Life Sci       Date:  1966-08       Impact factor: 5.037

View more
  20 in total

1.  Proceedings: A centrally-acting antihypertensive agent R28935, a pimozide analogue, not acting via alpha-adrenergic neurones.

Authors:  L Finch
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Pressor response induced by local anaesthetics perfused through the cerebral ventricles of dogs.

Authors:  P S Haranath; G Indira-Narayan; H Venkatakrishna-Bhatt
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

3.  The subdivision of beta-adrenoceptors in the cardiovascular system of the rat.

Authors:  F J Imms; R L Neame; D A Powis
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

4.  Drinking behaviour in the cat induced by renin, angiotensin I, II and isoprenaline.

Authors:  M J Cooling; M D Day
Journal:  J Physiol       Date:  1975-01       Impact factor: 5.182

Review 5.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

6.  Pharmacology of guanfacine.

Authors:  G Scholtysik
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

7.  Pressor responses to noradrenaline administered into the third cerebral ventricle of anaesthetized and conscious cats [proceedings].

Authors:  M D Day; R H Poyser; J Sempik
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

8.  Cardiovascular responses to centrally administered adrenaline in spontaneous hypertensive rats [proceedings].

Authors:  K R Borkowski; L Finch
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

9.  Centrally induced hypotension and bradycardia after administration of alpha-methylnoradrenaline into the area of the nucleus tractus solitarii of the rat.

Authors:  W De Jong; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

10.  Presence of beta-adrenoreceptors in the hypothalamus; their importance for the pressor response to hypothalamic stimulation.

Authors:  A Philippu; E Kittel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.